FIELD: medicine, ophthalmology.
SUBSTANCE: the present innovation deals with treating acute anterior and posterior ischemic optic neuropathy due to introducing vasodilators and anticoagulants as caffeine, halidor, dicinon in complex therapy in hospital for 10 d. Moreover, it is necessary to perform parabulbar introduction of 0.3 ml dexasone, 0.2 ml caffeine, 0.3 ml emoxipin successively, fractionally every 20 min once daily in combination with daily intramuscular injections once daily of 2.0 ml dicinon and 1.0 ml halidor and intravenous injection of haemodesum by drops per 200.0 ml on the 1st, 3d and 5th d of therapy. Also, it is necessary to carry out 5 seances of hirudotherapy for temple area every other day under coagulogram control. Then one should introduce milgamma, dicinon and nootropil at age-dependent dosages for 1 mo ambulatorily. The innovation provides complex improvement of microcirculation and metabolicocular and cerebral processes, regeneration of nervous tissue and reconstruction of optic nerve's conductivity at decreased frequency of therapeutic side effects.
EFFECT: higher efficiency of therapy.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE TREATMENT OF ACUTE OPTIC NEUROPATHY IN DRUSEN OF THE OPTIC NERVE HEAD | 2022 |
|
RU2794569C1 |
METHOD OF TREATING OPTIC NEUROPATHY AFTER CRANIOCEREBRAL INJURY IN REMOTE PERIOD | 2009 |
|
RU2398553C1 |
METHOD FOR TREATING OPTIC NEURITIS AT OPTICOCHIASMIC ARACHNOIDITIS AT REMISSION STAGE | 2005 |
|
RU2284814C1 |
METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
METHOD OF TREATING TOXIC OPTIC NEUROPATHY, INDUCED BY LONG INTAKE OF CODEINE-CONTAINING MEDICATIONS | 2010 |
|
RU2424796C1 |
METHOD OF TREATING CHRONIC TOXIC ALCOHOL- AND TOBACCO-RELATED OPTIC NEUROPATHY | 2010 |
|
RU2440074C1 |
METHOD OF TREATING INVOLUTIONAL EYE DISEASES | 2011 |
|
RU2565840C2 |
METHOD OF TREATING LUETIC OPTIC NEUROPATHY | 2012 |
|
RU2494775C1 |
METHOD OF OPTICAL NEURITIS TREATMENT | 2009 |
|
RU2414900C1 |
METHOD FOR STIMULATING VISION FUNCTION IN LENS SUBLUXATION CASES ACCOMPANIED WITH CONNECTIVE TISSUE SYSTEM METABOLISM DISORDERS | 2006 |
|
RU2306906C1 |
Authors
Dates
2006-08-10—Published
2005-01-14—Filed